{"id":"https://openalex.org/W2015411250","doi":"https://doi.org/10.1016/j.jphs.2014.11.010","title":"Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication","display_name":"Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication","alternate_titles":[],"publication_year":2014,"publication_date":"2014-12-12","ids":{"openalex":"https://openalex.org/W2015411250","doi":"https://doi.org/10.1016/j.jphs.2014.11.010","mag":"2015411250","pmid":"https://pubmed.ncbi.nlm.nih.gov/25704012"},"language":"en","primary_location":{"id":"doi:10.1016/j.jphs.2014.11.010","doi":"https://doi.org/10.1016/j.jphs.2014.11.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2014.11.010","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1347861314000176/pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2015411250"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S1347861314000176/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032453300","display_name":"Kenji Hashimoto","orcid":"https://orcid.org/0000-0002-8892-0439","observed_orcids":["https://orcid.org/0000-0002-8892-0439"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]},{"id":"https://openalex.org/I4210162351","display_name":"Center for Forensic Mental Health, Chiba University","ror":"https://ror.org/05b0gpy83","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kenji Hashimoto","raw_affiliation_strings":["Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan. Electronic address: hashimoto@faculty.chiba-u.jp","Division of Clinical Neuroscience Chiba University Center for Forensic Mental Health Chiba Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan. Electronic address: hashimoto@faculty.chiba-u.jp","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]},{"raw_affiliation_string":"Division of Clinical Neuroscience Chiba University Center for Forensic Mental Health Chiba Japan","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032453300"],"corresponding_institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"],"apc_list":{"value":2070,"currency":"USD","value_usd":2070},"apc_paid":{"value":2070,"currency":"USD","value_usd":2070},"fwci":0.8832,"has_fulltext":true,"cited_by_count":118,"citation_normalized_percentile":{"value":0.59801489,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"127","issue":"1","first_page":"6","last_page":"9"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11150","display_name":"Endoplasmic Reticulum Stress and Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sigma-1-receptor","display_name":"sigma-1 receptor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sigma-1-receptor-agonist","display_name":"sigma-1 receptor agonist","score":0.8740000128746033},{"id":"https://openalex.org/keywords/molecular-chaperones","display_name":"molecular chaperones","score":0.652999997138977},{"id":"https://openalex.org/keywords/endoplasmic-reticulum","display_name":"endoplasmic reticulum","score":0.9229999780654907},{"id":"https://openalex.org/keywords/neuropsychiatric-disorders","display_name":"neuropsychiatric disorders","score":0.9100000262260437},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9120000004768372},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.968999981880188},{"id":"https://openalex.org/keywords/donepezil","display_name":"donepezil","score":0.8569999933242798},{"id":"https://openalex.org/keywords/ifenprodil","display_name":"ifenprodil","score":0.9929999709129333},{"id":"https://openalex.org/keywords/neurosteroids","display_name":"neurosteroids","score":0.8450000286102295},{"id":"https://openalex.org/keywords/nmda-receptor-antagonism","display_name":"NMDA receptor antagonism","score":0.6919999718666077},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.8410000205039978},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.6499999761581421},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9700000286102295},{"id":"https://openalex.org/keywords/delirium","display_name":"delirium","score":0.8700000047683716},{"id":"https://openalex.org/keywords/posttraumatic-stress-disorder","display_name":"post-traumatic stress disorder","score":0.9010000228881836}],"concepts":[{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.8721018433570862},{"id":"https://openalex.org/C103133801","wikidata":"https://www.wikidata.org/wiki/Q408572","display_name":"Sigma-1 receptor","level":4,"score":0.7557098865509033},{"id":"https://openalex.org/C2780376555","wikidata":"https://www.wikidata.org/wiki/Q5991156","display_name":"Ifenprodil","level":4,"score":0.7011188864707947},{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.6027982234954834},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5704832077026367},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.532813549041748},{"id":"https://openalex.org/C44796713","wikidata":"https://www.wikidata.org/wiki/Q2659374","display_name":"Neuroactive steroid","level":4,"score":0.5252801179885864},{"id":"https://openalex.org/C2777052854","wikidata":"https://www.wikidata.org/wiki/Q7512419","display_name":"Sigma receptor","level":3,"score":0.47929567098617554},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.43063879013061523},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41106122732162476},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.37730830907821655},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.36150938272476196},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.30014604330062866},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2810605466365814},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.2523496747016907},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.24587512016296387},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2410689890384674},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.15145763754844666},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.11400994658470154},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077265","descriptor_name":"Donepezil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000097605","descriptor_name":"Sigma-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008959","descriptor_name":"Models, Neurological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017480","descriptor_name":"Receptors, sigma","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D017480","descriptor_name":"Receptors, sigma","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018377","descriptor_name":"Neurotransmitter Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jphs.2014.11.010","doi":"https://doi.org/10.1016/j.jphs.2014.11.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2014.11.010","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1347861314000176/pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:25704012","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25704012","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacological sciences","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:15c3541b6d4743a3902bba6626e31eea","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/15c3541b6d4743a3902bba6626e31eea","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacological Sciences, Vol 127, Iss 1, Pp 6-9 (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.jphs.2014.11.010","doi":"https://doi.org/10.1016/j.jphs.2014.11.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2014.11.010","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1347861314000176/pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1132259659","display_name":null,"funder_award_id":"24116006","funder_id":"https://openalex.org/F4320320912","funder_display_name":"Ministry of Education, Culture, Sports, Science and Technology"}],"funders":[{"id":"https://openalex.org/F4320320912","display_name":"Ministry of Education, Culture, Sports, Science and Technology","ror":"https://ror.org/048rj2z13"},{"id":"https://openalex.org/F4320325182","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2015411250.pdf","grobid_xml":"https://content.openalex.org/works/W2015411250.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W161356906","https://openalex.org/W1942652330","https://openalex.org/W1970705129","https://openalex.org/W1970897378","https://openalex.org/W1981373150","https://openalex.org/W1994224293","https://openalex.org/W1996799348","https://openalex.org/W1997566439","https://openalex.org/W2003532781","https://openalex.org/W2004450011","https://openalex.org/W2010543372","https://openalex.org/W2019079031","https://openalex.org/W2019320775","https://openalex.org/W2029583595","https://openalex.org/W2037506486","https://openalex.org/W2039320407","https://openalex.org/W2053273968","https://openalex.org/W2080092700","https://openalex.org/W2091828873","https://openalex.org/W2092572691","https://openalex.org/W2093653250","https://openalex.org/W2110011082","https://openalex.org/W2113902650","https://openalex.org/W2118302279","https://openalex.org/W2120046395","https://openalex.org/W2123950263","https://openalex.org/W2131087015","https://openalex.org/W2141088264","https://openalex.org/W2153965166","https://openalex.org/W2319946110"],"related_works":["https://openalex.org/W2123950263","https://openalex.org/W2597065179","https://openalex.org/W2019569032","https://openalex.org/W2047193476","https://openalex.org/W2319946110","https://openalex.org/W1981373150","https://openalex.org/W2398651195","https://openalex.org/W2028646442","https://openalex.org/W2118955023","https://openalex.org/W2000941955"],"abstract_inverted_index":{"Endoplasmic":[0],"reticulum":[1],"(ER)":[2],"protein":[3],"sigma-1":[4,35,76,80,114,123,140,182],"receptor":[5,36,77,81,115,124,141,183],"represents":[6],"unique":[7],"chaperone":[8],"activity":[9],"in":[10,40,49,93,116,128,150,156,159,164,188],"the":[11,41,50,85,117,129,151,172,178,189],"central":[12],"nervous":[13],"system,":[14],"and":[15,56,72,145,162],"it":[16],"exerts":[17],"a":[18,22,38],"potent":[19],"influence":[20],"on":[21],"number":[23],"of":[24,29,34,43,52,107,132,153,181],"neurotransmitter":[25],"systems.":[26],"Several":[27],"lines":[28],"evidence":[30],"suggest":[31,138],"that":[32,61,103,122,139],"activation":[33],"plays":[37],"role":[39],"pathophysiology":[42],"neuropsychiatric":[44,190],"diseases,":[45],"as":[46,48,75],"well":[47],"mechanisms":[51,131],"some":[53,62],"therapeutic":[54,130],"drugs":[55],"neurosteroids.":[57],"Preclinical":[58],"studies":[59],"showed":[60],"selective":[63],"serotonin":[64],"reuptake":[65],"inhibitors":[66],"(SSRIs;":[67],"fluvoxamine,":[68,144],"fluoxetine,":[69],"excitalopram),":[70],"donepezil,":[71],"ifenprodil":[73],"act":[74],"agonists.":[78],"Furthermore,":[79],"agonists":[82],"could":[83,111],"improve":[84],"N-methyl-D-aspartate":[86],"(NMDA)":[87],"antagonist":[88],"phencyclidine":[89],"(PCP)-induced":[90],"cognitive":[91,154],"deficits":[92],"mice.":[94],"A":[95],"study":[96],"using":[97],"positron":[98],"emission":[99],"tomography":[100],"have":[101],"demonstrated":[102],"an":[104],"oral":[105],"administration":[106],"fluvoxamine":[108],"or":[109],"donepezil":[110],"bind":[112],"to":[113,176],"healthy":[118],"human":[119],"brain,":[120],"suggesting":[121],"might":[125],"be":[126,148],"involved":[127],"these":[133],"drugs.":[134],"Moreover,":[135],"case":[136],"reports":[137],"agonists,":[142,184],"including":[143,185],"ifenprodil,":[146],"may":[147],"effective":[149],"treatment":[152],"impairment":[155],"schizophrenia,":[157],"delirium":[158],"elderly":[160],"people,":[161],"flashbacks":[163],"post-traumatic":[165],"stress":[166],"disorder.":[167],"In":[168],"this":[169],"review":[170],"article,":[171],"author":[173],"would":[174],"like":[175],"discuss":[177],"clinical":[179],"implication":[180],"endogenous":[186],"neurosteroids,":[187],"diseases.":[191]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2015411250","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":19},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
